Clinical Trial Update: Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4

View source ↗

Summary

A completed multicenter prospective study evaluated the use of ROMA and RMI algorithms along with CA125 and HE4 to differentiate benign from malignant ovarian t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Tumor

Snippet

Sponsor: Centre Hospitalier Departemental Vendee | Conditions: Ovarian Tumor, Ovarian Cancer | Status: COMPLETED | Results posted: 2024-03-15